Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England




Share Price Information for Innovaderma (IDP)


Share Price: 94.00Bid: 93.00Ask: 95.00Change: 0.00 (0.00%)No Movement on Innovaderma
Spread: 2.00Spread as %: 2.15%Open: 94.00High: 94.00Low: 94.00Yesterday’s Close: 94.00

Innovaderma Plc Ord Eur0.10

Innovaderma is part of the Personal Goods sector






Share Price SpacerPrice
94.00
Share Price SpacerBid
93.00
Share Price SpacerAsk
95.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
25,864
Share Price SpacerOpen
94.00
Share Price SpacerHigh
94.00
Share Price SpacerLow
94.00
Share Price SpacerClose
94.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 14.50m £13.63m 3,000

52 Week High 207.50 52 Week High Date 19-SEP-2018
52 Week Low 70.50 52 Week Low Date 11-JAN-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 20,614 5,250 31.333 3.00 0.00 0.00


London South East Users info for Innovaderma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-May-19
15:03:55
94.35
5,250
Buy* 
93.00
95.00
4,953
Trade Type:
Ordinary

21-May-19
12:00:25
93.00
1,707
Sell* 
93.00
95.00
1,588
Trade Type:
Ordinary

21-May-19
09:55:56
93.00
5,000
Sell* 
93.00
95.00
4,650
Trade Type:
Ordinary




View more Innovaderma trades >>

Directors Deals for Innovaderma (IDP)
Trade DateActionNotifierPriceCurrencyAmountHolding
13-May-19Buy
Trade Notifier Information for InnovaDerma
Ross Andrews held the position of Non-Executive Director at InnovaDerma at the time of this trade.
 Ross Andrews
94.4GBX15,00030000
24-Apr-19Buy
Trade Notifier Information for InnovaDerma
Kieran Callan held the position of CEO at InnovaDerma at the time of this trade.
 Kieran Callan
97GBX4,80015800
26-Feb-19Buy
Trade Notifier Information for InnovaDerma
Joe Bayer held the position of Executive Director at InnovaDerma at the time of this trade.
 Joe Bayer
86GBX5,000121513
View more Innovaderma directors dealings >>


shandypants2
Posts: 111
Opinion:No Opinion
Price:94.00
RE: Feeling confident for Med & L/term
Today 16:32
Roots did £650k H1 (up 252% on H1 2018, which was from zero during that period). This disappointed me as I was hoping for £1m (as H2 2018 was over £700k).

FinnCap has previously estimated £2.7m for Roots this year but I think this is based on decent sales from Tesco and I am not convinced it has taken off here. I think Asda will be similar - £10 is a lot for a shampoo during your grocery shop.

Boots should be doing better as a premium shampoo is more suited here but poor shelf space and lack of promotions may have had an impact.

At a minimum it should do £1.5m (I'm still hoping for £2m). This is based on product extensions, better DTC 9now 27k facebook followers) and higher Boots sales in H2 than H1 plus some contribution from Tesco and Asda.

Think Prolong was doing £1k a day without marketing so that would equate to £350k for full year. H2 marketing kicked in so hopefully sales have increased a bit. Agree Prolong has thus far disappointed - ideal for DTC and this is what IDP are meant to excel at
Jam4u
Posts: 1,112
Premium Chat Member
Opinion:No Opinion
Price:94.00
RE: Feeling confident for Med & L/term
Today 15:55
I am no expert on how targets are supposed to be announced but my take has been from previous years that they worked with/informed the House Broker.

I believe there is no need for them to formally announce anything unless they expect more than 10% variance from the target which at 13.2m falls within that tolerance level. As I say I dont know this tolerance rule as a fact just going by what others have posted. If you want to get it confirmed yourself, then it should be easy enough to get it directly confirmed by talking to the PR Company.

On your numbers, I am not sure how you got £2m from for Roots given the H1 number was £265k I believe. I do think that SkinnyTan will be higher at around 10.5 to 11.0m with the rest from Roots, C+L etc. I think all the other products wont be material at all for this year. Good news though, is that we hav eth egrowth on these to leverage for next year!

If skinnyTan comes in at 10m then mcap for just SkinnyTan should imo be £20m. and every additional 1m would be worth another circa £4m to the mcap I reckon. I'm basing that on what we know St Tropez sold for back in 2010. That all said, I am hoping for £11m for Skinny Tan this year.

Re ProLong, I am not convinced that things are going so well there with that one - its way late, we havent heard anything on it and I am yet to be convinced that IDP can get the sales volumes that justify Haris having paid over £1m for it, not to mention the royalty payments and consultancy fees. That said, if they can finally get this off the ground and show they can grow revs with it then very happy days indeed.

If they can deliver half-decent numbers this year then I will be very optimistic (like VERY) for the prospects of IDP over the next 12 to 24 months.
shandypants2
Posts: 111
Opinion:No Opinion
Price:94.00
RE: Feeling confident for Med & L/term
Today 15:27
Whilst FinnCap reduced YE target to £13.2m the last update from IDP was the AGM statement that said earning would be approximately £14m. Surely if the lower target is being used IDP should have informed someone?? As I said I'm still expecting £13m but will accept £12.8m.

The FinnCap revised YE19 target (released on 21/2/19) of £13.2m and profit of £1.5m also sneaked in a lower 2020 target of £15.4m (profit of £2.4m) - previously this was £17.5m and £2.7m profit. Have to admit I didn't notice this at the time.

My estimates for this year are:
Roots - £2m
Prolong (and Growlase) - £500k
C+L - 250k
ST- minimum of £10m (think it did c£9.5m last year without Boots)

Next year with full year retail deals for Roots and ST in the UK and potential country expansion for all 5 brands I think another 20% growth is quite conservative. I think Prolong should be doing £1m plus if combined with a European roll out.

Agree with the cash position - however we did have over £2m in stock though at YE18 (valued at cost price not retail) so utilising this better will help, although this may need to increase due to increased retail deals
Jam4u
Posts: 1,112
Premium Chat Member
Opinion:No Opinion
Price:94.00
RE: Feeling confident for Med & L/term
Today 14:06
One thing is for sure, we are (on any metric) stupidly undervalued. The posting of numbers in June/July will help validate this. The company though need to improve (like day & night improve) on the Market comms, RNS releases and general engagement. Once they've mastered that alongside (hopefully) delivering numbers then I really do see no reason why the sp cant be getting back towards previous highs (all in time of course). But for me, the growth prospects here are staggering especially given the risk profile. It is though a l/t value play and not one where it will happen overnight. AIMO.
Jam4u
Posts: 1,112
Premium Chat Member
Opinion:No Opinion
Price:94.00
RE: Feeling confident for Med & L/term
Today 13:27
Thanks Shandypants - where did you get the 2020 numbers from? I would have said 12.8m would be great, but also conscious they dropped some in the H1. But agree as each day goes by it does feel confidence here is increasing. If they hit the numbers and with what is now in the pipeline (eg. ProLong, GrowLase and Charle+Lee) in addition to growing Roots and SkinnyTan then we should have a stella 2020.

The only limitation then is managing and turning around the positive cash flows to keep growth rates up. I would imagine without any new money there is a limit to how much IDP could actually grow organically - I would suggest 30 to 40% is absolute limit which would be great anyway.

I'm very happy indeed if this all materialises, as no way could the sp stay below £2 imo.
View more share chat for Innovaderma (IDP) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.